Diabetes Group Visits

Share your experience of developing a diabetes group visit. Include your "messes" and "successes"--they will help all our members better implement group visits in their practice.

Diabetes Quality Markers and Office Re-design

What are some examples of office/practice re-design areas you've implemented to help in meeting diabetes quality markers?

August 2009 Blog Question

Do you plan to make any changes in your pratice to integrate a 'look ahead' approach to treat your patients with diabetes? If so, what plans do you have?

July 2009 Blog Question

Patients with diabetes and depression are a tremendous challenge in primary care. How are you managing these patients and what type of information do you need to improve the care of these patients?

May 2009 Blog Questions on Patient Adherence

What are your greatest challenges in helping patients accept and adhere to lifestyle changes?

What strategies have worked for you?

April 2009 Blog Questions on Saxagliptin

In your opinion, how is emergence of a new DPP-4 inhibitor (saxagliptin) influencing care of patients with type 2 diabetes?

Do you view these changes as positive?


If approved, what role do you predict saxagliptin will have in managing patients with type 2 diabetes?

March 2009 PCMG Blog Question

How have the results of VADT and ACCORD changed the way you manage your patients with type 2 diabetes?

December PCMG Blog Questions on JUPITER

• Do you normally obtain hs-CRP levels on your asymptomatic patients with normal LDL-cholesterol levels?
  
• Do you plan to switch any of your patients from their current statin therapy to rosuvastatin? If so, why?
  
• What other cardiovascular inflammatory markers are you currently screening for in your intermediate and high risk patient populations?
  
• How are the pharmaceutical representatives in your area for Merck and Pfizer handling the news about JUPITER?
  
• Are any of your patients coming to you and specifically asking you, as their physician, to place them on Crestor, based upon the results of JUPITER?

Neuroinflammation and Chronic Pain

Please share any interesting patients who may experience neuroinflammation with our membership. These are complicated pain management issues. We encourage other members to offer their expertise and pain management strategies.

Vitamin D Deficiency

Are you obtaining serum vitamin D levels routinely in your patients with cardiovascular disease, osteoporosis and diabetes?

Are you advising patients at high risk for CVD to spend at least 15 minutes daily outside exposed to sunlight?

What are your views on the ACCORD and ADVANCE trials?

Have any of you observed any unusual cases of insulin reactions such as lipoatrophy?
How do they affect your patient’s glycemic control?
What tricks do you use to determine the cause of the insulin reactions?
How do you counsel them on altering their injection behaviors?

What are your thoughts on the ACCORD trial?

How are you treating your diabetes patients who may be considered as being "brittle"?

How are you currently managing your patients with prediabetes?

Do any of your patients have androgen deficiency syndrome? If so, how did you diagnose them and what treatments have you prescribed?

What are your thoughts on the recent removal of Exubera from the market?

What are your current treatment plans for your patients taking a TZD?

We are curious to hear your responses to this question. Please feel free to post a response!